Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Larry Todd Edwards is set to sell 3,725 shares of common stock on October 2, 2024. The shares, valued at an aggregate market value of $37,295, were acquired through a restricted stock vest on October 1, 2024, directly from Arcutis Biotherapeutics. This transaction follows a period where no securities were sold by Edwards in the past three months, as per the provided transaction history.